Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
McKesson
McKinsey
Medtronic
Dow

Last Updated: November 14, 2019

DrugPatentWatch Database Preview

Litigation Details for Astellas Pharma Inc. v. Roxane Laboratories, Inc. (D. Del. 2017)

See Plans and Pricing

« Back to Dashboard

Astellas Pharma Inc. v. Roxane Laboratories, Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-05-09
Court District Court, D. Delaware Date Terminated 2018-12-07
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties ASTELLAS PHARMA INC.; ASTELLAS PHARMA US, INC.; ASTELLAS US LLC; HIKMA PHARMACEUTICALS PLC; MEDIVATION PROSTATE THERAPEUTICS, INC.; MEDIVATION, INC.; REGENTS OF THE UNIVERSITY OF CALIFORNIA; ROXANE LABORATORIES, INC.; WEST-WARD PHARMACEUTICALS CORP.; WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED
Patents 7,709,517; 8,183,274; 9,126,941
Attorneys Charles B. Klein; Derek James Fahnestock; Eve H. Ormerod; Jack B. Blumenfeld; Neal C. Belgam; Samuel S. Park; Sharick Naqi; Zachary L. Sorman
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Astellas Pharma Inc. v. Roxane Laboratories, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Astellas Pharma Inc. v. Roxane Laboratories, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 United States Patent Nos. 7,709,517 (“the ’517 patent”), 8,183,274 (“the ’274 patent”), and 9,126,941…infringed one or more claims of United States Patent Nos. 7,709,517, 8,183,274, and 9,126,941 by submitting…infringe one or more claims of United States Patent Nos. 7,709,517, 8,183,274, and 9,126,941 under 35 U.S.C…to the expiration dates of United States Patent Nos. 7,709,517, 8,183,274, and 9,126,941, inclusive of… the expiration dates of United States Patent Nos. 7,709,517, 8,183,274, and 9,126,941, inclusive of External link to document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,709,517 B2; 8,183,274 B2; 9,126,941…2017 7 December 2018 1:17-cv-00542 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Merck
Express Scripts
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.